Fig. 3.
Cumulative incidence of chronic GVH disease.
Incidence in day +80 survivors after MSD (n = 343), matched (n = 992), or partially matched (n = 241) URD BMT for CP CML. By 2 years, MSD 53% ± 5%, 60% ± 3% matched, and 60% ± 6% partially matched URD developed chronic GVH disease,P = .07.